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Abstract
Purpose—Sampling of arterial blood for metabolite correction is often required to define a true 
radiotracer input function in quantitative modeling of PET data. However, arterial puncture for 
blood sampling is often undesirable. To establish whether venous blood could substitute for 
arterial blood in metabolite analysis for quantitative PET studies with 1-[11C]acetate and 1-
[11C]palmitate, we compared the results of [11C]CO2-metabolite analyses performed on 
simultaneously collected arterial and venous blood samples.
Methods—Paired arterial and venous blood samples were drawn from anesthetized pigs at 1, 3, 
6, 8, 10, 15, 20, 25 and 30 minutes after i.v. administration of 1-[11C]acetate and 1[11C]palmitate. 
Blood radioactivity present as [11C]CO2 was determined employing a validated 10-minutes gas-
purge method. Briefly, total blood 11C radioactivity was counted in base-treated [11C]-blood 
samples, and non-[11C]CO2 radioactivity was counted after the [11C]-blood was acidified using 
6N HCl and bubbled with air for 10 minutes to quantitatively remove [11C]CO2.
Results—An excellent correlation was found between concurrent arterial and venous [11C]CO2 
levels. For the [11C]acetate study, the regression equation derived to estimate the venous 
[11C]CO2 from the arterial values was:y = 0.994x + 0.004 (r2=0.97), and for the[11C]palmitate: y 
= 0.964x -0.001 (r2=0.9).Over the 1-30 minute period, the fraction of total blood 11C present as 
[11C]CO2 rose from 4% to 64% for acetate, and 0% to 24% for palmitate. The rate of [11C]CO2 
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appearance in venous blood appears similar for the pig model and humans following i.v. [11C]-
acetate administration.
Conclusion—Venous blood [11C]CO2 values appear suitable as substitutes for arterial blood 
samples in [11C]CO2 metabolite analysis after administration of [11C]acetate or [11C]palmitate.
Advances in Knowledge and Implications for Patient Care—Quantitative PET studies 
employing 1-[11C]acetate and 1-[11C]palmitate can employ venous blood samples for metabolite 
correction of an image-derived tracer arterial input function, thereby avoiding the risks of direct 
arterial blood sampling.
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1. Introduction
Simple carboxylic acids radiolabeled with carbon-11 (t1/2: 20.4 min), especially [11C]acetate 
and [11C]palmitate, have been used widely as tools for imaging with positron emission 
tomography (PET) to evaluate the rate at which their endogenous counterparts are being 
oxidatively metabolized by myocardium under various physiological conditions. One of the 
major radiolabeled metabolites produced by these compounds is [11C]CO2, a product of the 
tricarboxylic acid cycle. Models for quantification of myocardial metabolic rate from the 
resulting PET data require knowledge of both the concentration of radioactivity in 
myocardium as a function of time, as well as knowledge of the concentration of 
radiopharmaceutical in the arterial blood supplying that tissue. While the PET images 
readily quantify radioactivity in the myocardium, as well as the arterial blood radioactivity 
(based on a region of interest in the cavity of the left ventricle or left atrium), those PET data 
simply define regional radionuclide concentrations without information on the chemical 
form of the radionuclide. Thus, for tracer kinetic modeling to quantify metabolic rates, it is 
necessary to independently measure the fraction of total blood 11C activity present in blood 
as [11C]CO2 to generate a correct radiopharmaceutical arterial input function.
The technique most commonly used to determine the radiolabeled CO2 concentration of 
blood is simplein vitro acidification of a blood sample, followed by purging with an inert 
gas to drive off CO2. The fraction of total blood 11C activity that remains after the gas purge 
represents 11C species other than 11CO2. This method has been used in a number of 
preclinical and clinical PET studies yielding important insights into myocardial metabolism. 
Here we report experimental validation of the selectivity of the gas-purge technique for 
removing 11CO2 from blood. Since direct arterial cannulation for blood sampling is 
invasive, painful, and can result in undesirable complications, we have then applied this 
analytical method to assess whether arterial blood [11C]CO2 concentrations following 
administration of [11C]acetate and [11C]palmitate can be accurately, and less invasively, 
estimated by the [11C]CO2 levels of venous blood.
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2. Materials and Methods
2.1 General
The [11C]CO2, 1-[11C]acetate, and 1-[11C]palmitate radiotracers were obtained from the 
Radiochemistry Core of the Indiana Institute for Biomedical Imaging Sciences (IIBIS). The 
1-[11C]acetate and 1-[11C]palmitate tracers were prepared following the published methods. 
The [11C]CO2 in aqueous solution was obtained by dissolving the no-carrier-added 
[11C]CO2 gas in a 2 mL sodium hydroxide (100mM) solution. The resultant sodium 11C-
bicarbonate solution was then mixed with 3 mL of saline. The final solution contained 10-15 
mCi/mL (370-555 MBq/mL). Theheparanized blood samples used for the air purge 
validation study were taken from the arterial line of swineprior to initiation of planned PET 
studies. Heparinized blood samples for the arterial-venous comparison study were obtained 
from four mature miniature pigs (male; ∼25kg) at specified times after sequential injection 
of 1-[11C]acetate and 1-[11C]palmitate(allowing ∼90-minutes between injections for decay 
of the prior dose). Arterial blood samples were drawn from the carotid artery, while venous 
blood was sampled from the jugular vein. The pigs were anesthetized with 1-3% isoflurane 
and mechanically ventilated throughout the period of the study. The protocol for the animal 
studies was approved by the Indiana University Animal Care and Use Committee. 
Radioactivity measurements were made by dose calibrator or NaI(Tl) automatic gamma 
counter (Beckman Gamma 8000).
2.2 Validation of protocol for the determination of [11C]CO2 in blood
Radioactive sample handling was carried out behind lead-shielding in a chemical fume 
hood. A 50-100 μCi sample (20-100 μL) of aqueous [11C]CO2 or [11C]acetate or 
[11C]palmitate/HSA was added to 3 mL of blood in vitro and gently mixed. A 1 mL aliquot 
of the blood was then transferred to a counting vial containing 1 mL sodium hydroxide(0.1 
N) and 3 mL isopropanol, which was then immediately capped to retain any 11CO2 as 
bicarbonate. This base-treated blood contained all 11C radioactivity (vial A). A second 1 mL 
aliquot of the blood containing radiotracer was added to a counting vial containing 1 mL 
sodium bicarbonate (0.5 N) and 3 mL isopropanol, and the mixture was vortex mixed. Then, 
1 mL 6N hydrochloric acid was added followed by 10-20 secondsof vortex mixing. Next, 
the acid-treated blood sample was purged with air,bubbled into the blood via a 4-inch 
flexible filter straw (B Braun Medical, Inc., Bethlehem, PA), for 10 and 15 minutes to drive 
off the 11CO2 (vial B). The activity remaining in “vial B” represents for total non-11CO2 
radioactivity. After decay correction of the radioactivity measurements to a common time 
point, the percentage of total radioactivity released as 11CO2 was calculated as:
2.3 Determination of [11C]CO2 in paired arterial and venous blood samples 
afterintravenous administration of [11C]acetate and [11C]palmitate
Paired arterial and venous blood samples (each 2-3 mL) were drawn simultaneously from 
anesthetized swine into heparinized syringes at 1, 3, 6, 8, 10, 15, 20, 25 and 30 min after i.v. 
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administration of 1-[11C]acetate (32.2±3.5 mCi; 1.19±0.1 GBq; n=4) or 1-[11C]palmitate 
(27.5±5.4 mCi;1.0±0.2 GBq; n=4). For each time point, a 1 mL aliquot of the blood was 
transferred to a counting vial containing 1 mL 0.1 N sodium hydroxide and 3 mL 
isopropanol, and then immediately capped to retain any 11CO2 as bicarbonate (vial A). A 
second 1 mL aliquot of each blood sample was added to a counting vial containing 1 mL of 
0.5 N sodium bicarbonate and 3 mL isopropanol. Then, 1 mL of 6N hydrochloric acid was 
added, and the acid-treated blood was vortex mixed.The mixture was then bubbled with air 
for 10 minutes to release 11CO2 (vial B). The 11C radioactivity in each vial was then 
measured with an automatic gamma counter, and after decay correction to a common time 
point, the fraction of total blood 11C present as [11C]CO2 was calculated as:
2.4 Analysis of blood 11CO2 after [11C] acetate administration to humans
In conjunction with an IRB-approved study of [11C]acetate PET imaging in humans, the 
levels of [11C]CO2 were also determined in peripheral venous human blood samples. The 
blood was drawn from a forearm vein into heparinized syringes at 1, 3, 6, 8, 10, 15, 20, 25 
and 30 min (2-3 mL each) following i.v. administration of 1-[11C]acetate (876.9±140.6 
MBq;3 men and 3 women) and immediately analyzed following the procedures described 
above.
3. Results and Discussion
To verify the suitability of the gas purge method for the determining the level of blood-
borne [11C]CO2, analysis was carried out after directly mixing [11C]CO2 with whole blood 
in vitro. After acidification and air bubbling through the sample for 10-minutes, more than 
99% of the 11C was released from the [11C]CO2-spiked whole blood (Table 1). Continuation 
of the gas purge for an additional 5-minutes did not appreciably alter the residual blood 11C 
level. As expected, blood samples similarly spiked with [11C]acetate or [11C]palmitate 
showed no loss of radioactivity, even after 15 min of air purging (Table 1). These results are 
similar to previous reported findings, where 95% of [11C]acetate was retained, and 98% of 
[11C]-labeled bicarbonate was eliminated, in acid-treated blood samples after 10-minutes of 
inert gas bubbling. This validation study confirmed that the gas purge method was quite 
effective for selectively releasing [11C]CO2 from acid-treated whole blood. Additionally, the 
analysis method is technically straightforward, simple to implement, and can readily be 
completed on a time frame compatible with the 20-minute 11C half-life.
To evaluate whether venous blood sampling might reliably substitute for arterial blood 
sampling as this method is translated to support quantitative PET studies of acetate and 
palmitate metabolism in humans, we wanted to examine the correlation between arterial and 
venous blood [11C]CO2 concentrations after i.v. administration of [11C]acetate or 
[11C]palmitate. The kinetic models for quantification of tissue metabolism with [11C]acetate 
and [11C]palmitate require knowledge of the true tracer arterial blood time-activity curve, 
but direct arterial cannulation for blood sampling is undesirably invasive in human studies. 
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Reliance solely on the PET data for quantification of the total arterial blood level of 
radioactivity, coupled with venous blood sampling for metabolite analysis, is far more 
practical to implement in clinical studies. But, this latter approach is only valid if venous 
blood can be demonstrated to be a reasonable surrogate for quantifying the relative levels of 
parent tracer and metabolite(s) in arterial blood.
Paired arterial and venous blood samples were concurrently collected at 1, 3, 6, 8, 10, 15, 
20, 25 and 30 minutes after i.v. administration of either 1-[11C]acetate and 1-[11C]palmitate 
in four mini pigs at rest. (The length of each imaging session was 30-minutes, setting the 
final blood sampling time.) Each of the collected blood samples was analyzed immediately 
to determine the fraction of total blood radioactivity present as [11C]CO2.
An excellent correlation was found between the arterial and venous blood [11C]CO2 
concentrations at all times following [11C]acetate injection, with a correlation coefficient, 
r2=0.97 (n=34 pairs; Fig. 1A). For 11C-palmitate, there is also a good correlation between 
the measured fractions of radioactivity present as [11C]CO2 in arterial and venous blood (r2= 
0.9;n=26 pairs; Fig. 1B). Over the 1-30 minute period, the fraction of total blood 11C present 
as 11CO2rose from 4% to 64% for acetate, and from 0% to 24% for palmitate (Fig. 2). 
However, comparing [11C]acetate to [11C]palmitate, there is a marked difference in the rates 
at which total blood radioactivity comes to be dominated by the [11C]CO2 metabolite.
The concordance of the metabolite data for these paired venous and arterial blood samples 
has a significant impact on imaging study design. For PET studies to quantify the rates of 
tissue metabolism of [11C]acetate and/or [11C]palmitate, venous blood sampling will be 
adequate for determining the [11C]CO2 metabolite correction required in an image-derived 
arterial blood 11C time-activity curve. Since 11CO2 is exhaled, the simple mass balance 
obviously requires that arterial blood have a lower 11CO2 concentration than the venous 
blood entering the lungs (Fig.3). Our results, however, indicate the fractional loss of 11CO2 
from the labeled blood pool of CO2/H2CO3 is sufficiently small that blood samples from the 
vein remain a reasonable surrogate for defining the arterial blood level of the [11C]CO2 
metabolite after administration of 1-[11C]acetate and 1-[11C]palmitate.
Arterial blood time-radioactivity curves showed similarly rapid clearance of both 1-
[11C]acetate and 1-[11C]palmitate (Fig. 4). In the myocardium, [11C]acetate is converted to 
acetyl-CoA, and immediately enters the tricarboxylic acid cycle, where radioactive CO2 is 
produced as its end product. The fraction of blood 11C present as [11C]CO2 in arterial/
venous increased over time steadily, with the absolute [11C]CO2 concentration reaching a 
peak at about 10-15 min post injection, and then remaining stable until the end of imaging at 
30 minutes. As shown in Figure 2A, by 15 minutes after [11C]acetate administration, 
approximately 60-70% of the blood radioactivity was labeled bicarbonate, with the 
radioactivity of 11CO2/HCO3- contributing significantly to the blood radioactivity at even a 
few minutes post-radiopharmaceutical administration. These results are consistent with 
previous studies.
In the case of [11C]palmitate, approximately 25-30% of the blood radioactivity was present 
as 11CO2 at 20 min post-administration (Fig. 2A). This result is also similar to previously 
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reported findings. Unlike 1-[11C]acetate, the 16-carbon 1-[11C]palmitate has a more 
complicated biochemical fate. Some of the 1-[11C]palmitate undergoes β-oxidation, where a 
2-C fragment is released as acetyl-CoA and enters the citric acid cycle for complete 
oxidation. On the other hand, some of the 1-[11C]palmitate administrated may not undergo 
immediate oxidation, but instead be stored as triglyceride.
For comparison with the findings in the pig model, the levels of 11CO2 in venous blood were 
also measured in six human subjects after intravenous administration of 1-[11C]acetate(Fig. 
2B). The rate at which human blood radioactivity becomes predominantly 11CO2 is very 
similar to the findings in the pig model.
4 Conclusions
The 10-minute gas purge method is quite reliable for removing 11CO2 from blood. In 
modeling to quantify the rate of tissue oxidative metabolism using [11C]acetate and 
[11C]palmitate, [11C]CO2 levels measured in venous blood appear suitable as a surrogate for 
quantifying the metabolite contribution to total 11C-radioactivity in arterial blood.
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Fig. 1. 
Concordance of measured arterial and venous [11C]CO2 levels. For [11C]acetate (A), the 
data shown represent a total of 34 paired swine arterial and venous blood samples collected 
at times: 1, 3, 6, 8,10, 15, 20, 25 and 30 minutes post- i.v injection (y = 0.994x + 0.004; r2= 
0.97). At all time points from 1-30 minutes post-injection, venous and arterialblood 
concentrations of [11C]CO2 appear essentially identical.For [11C]palmitate (B), the data 
shown represent 26 paired blood samples collected at 6, 8, 10, 15, 20, 25 and 30 minutes 
post-i.v injection (y = 0.964x - 0.011; r2=0.9). Data from one and three minutes post 
injection of [11C]palmitate are omitted due to the absence of 11CO2 in blood.
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Fig. 2. 
Fractions of arterial and venous total blood radioactivity present as 11CO2 following i.v. 
administration of [11C]acetate and [11C]palmitate to miniaturepig (A; n =4), and human (B; 
n = 6).In pig, the percentage of 11CO2 rose from 4% to 64% for acetate, and 0% to 24% for 
palmitate, over a 30-minute period following the i.v administration of the indicated tracer. 
The rate of 11CO2 appearance in human blood following[11C]acetate administration is very 
similar to the finding in the pig model. Values given are% 11CO2 in blood (mean±S.D.)[x : 
arterial blood; ● : venous blood].
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Fig. 3. 
While exhaled 11CO2 precludes arterial and venous blood from having absolutely identical 
concentrations of the [11C]CO2 metabolite of [11C]acetate and [11C]palmitate, the data from 
this study indicates that venous blood samples remain an excellent surrogate for quantifying 
the fraction of blood 11C radioactivity present as [11C]CO2 after i.v. administration of these 
radiopharmaceuticals.
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Fig. 4. 
Representative normalized decay-corrected arterial blood time-radioactivity curves obtained 
from a single pig by direct measurement of 11C radioactivity in sampled arterial blood. The 
[11C]-acetate (A) and [11C]-palmitate (B) are both fairly cleared rapidly from blood, with 
the [11C]CO2 metabolite representing a significant fraction of the total radioactivity beyond 
a few minutes post-injection.
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Table 1
Effectiveness of the gas-purge method for selectively removing [11C]CO2 from acidified whole blood.
Radiopharmaceutical Added to Blood Percentage of initial 11C lost from blood sample after 10-minute air purge
11CO2 99.8 ± 0.3% (n = 4)
1-[11C]acetate
-0.1 ± 0.5% (n = 3) *
1-[11C]palmitate
-2.4 ± 1.9% (n = 3) *
All results were reported as the mean ± SD for the number of experiments performed (n)
*15 min of air purge
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